In 2018, VLET Holdings S. a. r. l. (a subsidiary of Abris CEE Mid-Market Fund III LP, managed by Abris Capital Partners Ltd.) acquired a majority stake in Velvet CARE Sp. z o.o.
With the introduction of the new owner, another five-year development plan was launched as part of the Velvet CARE 2025 Strategy. Its objective is once again to double the turnover, introduce Velvet CARE to the group of companies with a turnover exceeding PLN 1 billion and achieve the position of a leader across the entire Central and Eastern Europe.
Between 2018 and 2020, three other new processing lines were installed in the Klucze plant; one of them, on account of the international situation related to the pandemic and the restrictions in movement, was assembled and successfully started-up by the Velvet CARE employees independently, with virtual support offered by its manufacturer.
A major step in the implementation of the development strategy of Velvet CARE was purchase of 100% shares of MORACELL, the largest manufacturer of paper hygiene products in Czech Republic, in March 2020. This was the moment that marked the start of the formation of the Velvet CARE Group – comprising two companies, Velvet CARE in Poland and Moracell in Czech Republic.
Another milestone in building the position of Velvet Care was the construction and start-up of the third tissue machine in the Klucze plant. The modern TM8 machine, with respect to the technical parameters similar to the prior one, TM7, was started up at the end of 2021. It allowed for a significant increase of the company’s production capacity and for an ambitious outlook on the future.